Abstract
Vertebrate neuromuscular junctions (NMJs) contain specialized basal laminas enriched for proteins not found at high concentrations extrasynaptically. Alterations in NMJ basement membrane components can result in loss of NMJ structural integrity and lead to muscular dystrophies. We demonstrate here that the conservedCaenorhabditis elegans basement membrane-associated molecules nidogen/entactin (NID-1) and type XVIII collagen (CLE-1) are associated with axons and particularly enriched near synaptic contacts. NID-1 is concentrated laterally, between the nerve cord and muscles, whereas CLE-1 is concentrated dorsal to the ventral nerve cord and ventral to the dorsal nerve cord, above the regions where synapses form. Mutations in these molecules cause specific and distinct defects in the organization of neuromuscular junctions. The mutant animals exhibit mild movement defects and altered responses to an inhibitor of acetylcholinesterase and a cholinergic agonist, indicating altered synaptic function. Our results provide the first demonstration that basement membrane molecules are important for NMJ formation and/or maintenance in C. elegans and that collagen XVIII and nidogen can have important roles in synapse organization.
Introduction
Chemical synapses consist of a presynaptic terminal specialized for transmission of signals and a postsynaptic element with receptors for transducing signals. The well studied vertebrate neuromuscular junction (NMJ) (Sanes and Lichtman, 1999) is formed by a presynaptic neuron, a Schwann cell, and a postsynaptic muscle cell. These cells are separated by a specialized basement membrane (BM) within the NMJ synaptic cleft (Patton et al., 1998; Sanes and Yamagata, 1999). The major BM components are laminins (Colognato and Yurchenco, 2000), collagen types IV, XV, and XVIII (Kuhn, 1995; Myers et al., 1996; Musso et al., 1998), nidogens (also referred to as entactins) (Durkin et al., 1988; Mann et al., 1989;Kohfeldt et al., 1998), and heparan sulfate proteogylcans (HSPGs) (Yurchenco and Schittny, 1990; Timpl, 1994).
Laminins are heterotrimeric molecules consisting of noncovalently associated α, β, and γ chains. β2 chain-containing laminins are highly concentrated within the synaptic cleft and are not found at high concentration extrasynaptically (Sanes and Lichtman, 1999). The nidogen G3 domain binds the laminin γ1 chain with high affinity, whereas its G2 domain associates with type IV collagen and perlecan, which are also present within the synaptic cleft (Chiu and Ko, 1994; Sanes, 1997; Peng et al., 1999). Nidogen, collagen type IV, and perlecan are not restricted to the synaptic basal lamina but are broadly distributed in BMs.
The synaptic BM is essential for proper NMJ formation. Agrin, an HSPG, is required for acetylcholine receptor clustering, an early event in NMJ formation (Campanelli et al., 1992). Additional evidence for extracellular matrix (ECM) function in synapse formation comes from identification of muscular dystrophies caused by mutations in synaptic BM components (laminin β2) (Sunada et al., 1995), cell surface matrix receptors (integrin α7) (Burkin and Kaufman, 1999), and proteins linking these receptors to the cytoskeleton, e.g., dystrophin (Nonaka, 1998; Colognato and Yurchenco, 1999; Cohn and Campbell, 2000; Burkin et al., 2001). Loss of either laminin α2 or β2 chain results in gross NMJ abnormalities, whereas loss of α4 results in misregistration of presynaptic and postsynaptic structures (Noakes et al., 1995; Allamand et al., 1997; Patton et al., 2001). BM proteins can clearly have specific roles in the organization and function of neuromuscular junctions.
Type XV and XVIII collagens are closely related, widely expressed BM molecules that have N-terminal thrombospondin-like procollagen domains, collagenous domains with multiple interruptions, and highly conserved C-terminal NC1 domains (Kivirikko et al., 1994; Rehn and Pihlajaniemi, 1994). Collagen XVIII is expressed in the developing nervous system and found on peripheral axons (Musso et al., 1998). Humans and mice with mutations in type XVIII collagen show several eye abnormalities (Sertie et al., 2000; Fukai et al., 2002). In Caenorhabditis elegans, collagen XVIII has been shown to affect cell motility and axon guidance via the NC1/endostatin domains (Ackley et al., 2001; Kuo et al., 2001). Mice lacking the closely related collagen XV have mild skeletal muscle myopathy and increased susceptibility to cardiac injury (Eklund et al., 2001; Fukai et al., 2002). Neither collagen XVIII nor collagen XV has been reported to accumulate specifically at vertebrate synapses, nor has any role been described for these molecules at the NMJ.
Vertebrate nidogens are encoded by two genes, nidogen-1 and nidogen-2 (Kohfeldt et al., 1998). No overt phenotype was originally reported for mice deficient for nidogen-1 (Murshed et al., 2000) or nidogen-2 (Schymeinsky et al., 2002). However, a recent report indicates that nidogen-1-deficient mice display a loss of hindlimb motor control and spontaneous seizure-like symptoms, suggesting a deficit in nervous system function (Dong et al., 2002). Although both nidogens are widely distributed, a specific glycosylation form of nidogen-1 has been reported to be present at NMJs (Chiu and Ko, 1994).
Mutations in several C. elegans BM genes have been characterized, including type IV collagen chains emb-9 andlet-2 (Guo et al., 1991; Sibley et al., 1994; Gupta et al., 1997), nidogen nid-1 (Kang and Kramer, 2000; Kim and Wadsworth, 2000), perlecan unc-52 (Rogalski et al., 1995), and type XVIII collagen cle-1 (Ackley et al., 2001). NID-1 and CLE-1 are associated with the nervous system (Kang and Kramer, 2000; Ackley et al., 2001), whereas EMB-9, LET-2, and UNC-52 are not (Sibley et al., 1994; Graham et al., 1997; Mullen et al., 1999). Deletion of the NC1 domain of cle-1 can cause defects in the migration of several neurons (Ackley et al., 2001). Mutations innid-1 have been shown to cause defects in positioning of axons in the sublateral and ventral nerve cords (Kim and Wadsworth, 2000). unc-52, emb-9, and let-2 are required for viability and affect the development of several tissues, including the body wall muscles and pharynx (Mackenzie et al., 1978; Guo et al., 1991; Gupta et al., 1997). None of these BM proteins have previously been shown to have a role in synaptogenesis in C. elegans.We show here that CLE-1 and NID-1 are enriched near synapse-rich regions of the nervous system and are required for the proper organization of presynaptic zones in C. elegans. Mutations in cle-1 and nid-1 result in distinct defects in synapse organization and function, providing the first genetic evidence that BM-associated proteins are important for C. eleganssynaptogenesis.
Materials and Methods
Culture conditions. C. elegans culture and manipulation were performed using standard methods (Brenner, 1974). All strains were maintained at 20–23°C, unless specifically stated otherwise. The following strains were used: wild-type N2 var. Bristol, CH118 nid-1(cg118), CH119 nid-1(cg119) (Kang and Kramer, 2000), CH120 cle-1(cg120) (Ackley et al., 2001), CZ477 cle-1(ju34); juIs1, CB1072 unc-29(e1072) (Lewis et al., 1980a). The following integrated green fluorescent protein (GFP) neural marker strains were used: juIs1[Punc-25:: SNB-1:: GFP] (Hallam and Jin, 1998); juIs76[Punc-25:: GFP] (Huang et al., 2002).
PCR and sequencing. The cle-1(ju34) allele was sequenced as described (Ackley et al., 2001). The primers for detecting the ju34 deletion are as follows (nucleotide numbering from F39H11; GenBank AF164959): ex9F1 5′-GCCCCGCAGCTAGAGGTTTA-3′ (21559–21578) and ex9R1 5′-AACAATGCGAAGTGGCGATAC-3′ (22821–22841). Sequencing of genomic DNA from ju34 animals identified a discontinuous deletion in exon 17 of cle-1, removing nucleotides (nts) 22112–22333 and 22341–22467 and leaving seven nts, 22334–22340, intact (numbering based on cosmid F39H11; GenBank AF164959).
Mosaic analysis. Mosaic analysis was performed as described (Zhen and Jin, 1999) using nuclear SUR-5:: GFP as a marker for the array (Gu et al., 1998). Four animals that had lost the array in the muscle lineage were examined. Although no animals were generated that lost the array from the entire neural lineage, two animals were examined in which the array had been lost from large regions of the ventral cord.
Microscopy. Live epifluorescence microscopy was performed as described (Zhen and Jin, 1999; Ackley et al., 2001). Fluorescent and Nomarski images were obtained using a Zeiss Axiophot microscope equipped with a Photometrics Sensys CCD camera. Images were serially deconvolved using MicroTome software (VayTek, Fairfield, IA). Confocal images were acquired using a Zeiss LSM5 and processed using the Pascal Software (Zeiss).
Immunohistochemistry. Immunohistochemistry was performed as described (Finney and Ruvkun, 1990; Bettinger et al., 1996; Koushika et al., 2001). The antibodies used in this report are CeCol18 (Ackley et al., 2001), Ab1095 (SNT-1) (Nonet et al., 1993), αUNC-17 (Alfonso et al., 1993), and αNID-1 (Kang and Kramer, 2000).
Thrashing assay. Thrashing assays were based on Miller et al. (1996). Animals were picked into 50 μl of M9 buffer in individual wells of a 96-well cell-culture dish, with the experimenter blind to the genotype. Animals were allowed to equilibrate for 2 min and then observed for 2 min. A thrash was counted as a change of direction in body movement.
SNB:: GFP quantification. Images were quantified in Scion Image (Scion Corporation) after thresholding using the wand autocount function. Images were acquired on either a Zeiss LSM5 confocal microscope or aZeiss Axioskop and saved as TIFF images with a scale bar. The images were opened in Scion Image and converted to a binary image using the thresholding command. A line was used to measure the number of pixels along the scale bar that was used to set the pixels per micrometer scale in the program. The wand autocount counts the number of white pixels surrounded by black pixels in the thresholded image to arrive at the area. These numbers were exported to Microsoft Excel for statistical analyses.
Axon guidance. The juIs76 GFP marker (Huang et al., 2002) illuminates the cell bodies and processes of the 6 dorsal type D (DD) and 13 ventral type D (VD) motor neurons. The arrangement of the cell bodies in the ventral nerve cord provides 10 distinct regions to score axon guidance. VD processes (axons) abut but do not overlap with other VD processes, only DD processes (dendrites) and vice versa. Thus each region can be simplified to correspond to an overlap of a single VD axon with a single DD dendrite. We examined 48 animals (480 regions) of each genotype for defasciculation defects in the ventral cord. Numbers are presented as percentage of regions that showed a defasciculation defect, indicating that a process was displaced from the edge of the muscle where it would normally make synapses.
Video microscopy. An ∼1 × 1 mm square was drawn on a glass slide using a Pap pen (hydrophobic slide marker; Sigma, St. Louis, MO). M9 buffer (10–15 μl) was used to fill the square. Animals were picked into the liquid and allowed to equilibrate for 2 min. Images were acquired using the VidCap program (Freeware) using a Panasonic WV-CD110 analog camera on aZeiss Axiovert 35M inverted microscope. Movies were edited to current length using Adobe Premiere 5.1.
Pharmacologic assays. Levamisole-induced egg-laying assays were performed as described (Kim et al., 2001). Aldicarb resistance assays were done as described (Jorgensen et al., 1995). Briefly, adult animals were scored for body movement or pharyngeal pumping after 8 hr on normal growth medium containing the indicated concentration of aldicarb. Lethality was scored as a complete cessation of movement and pumping. Animals were scored as positive for pumping if they demonstrated continuous, vigorous pumping. Movement was scored as positive if any body wall muscle activity could be observed.
Results
CLE-1 and NID-1 are enriched near synapses
Most synapses in C. elegans form en passantalong axons and are observed as bulging varicosities along the processes (White et al., 1986). The ventral and dorsal nerve cords are situated between a medial epidermal (hypodermal) ridge and the more laterally positioned body wall muscles (Fig.1A). Body wall muscles extend processes, called muscle arms, to the nerve cords to receive innervation. In the ventral nerve cord, neuromuscular junctions are restricted to the lateral edge of the right fascicle, where it contacts the basement membrane at the muscle edge (Fig. 1B). The dorsal nerve cord is similarly organized, but on the left side of the midline.
The C. elegans nervous system is covered by a distinct basal lamina (White et al., 1986). However, the previously characterized basement membrane proteins, collagen IV and perlecan, have not been shown to be present in the neural basal lamina. We recently demonstrated that, in addition to being present in basement membranes throughout the animal, CLE-1 and NID-1 accumulate along the dorsal and ventral nerve cords and on the nerve ring (Kang and Kramer, 2000;Ackley et al., 2001). NID-1 is also associated with the sublateral nerve tracts. NID-1 and CLE-1 localize almost exclusively on nerve processes, not cell bodies, and associate with processes that travel anterior-posterior while generally being undetectable on dorsoventral processes, e.g., commissures, which do not contain synapses. NID-1 and CLE-1 staining is not necessarily distributed evenly along axon tracts but is strongest in the regions where synapses are abundant and is often in a punctate pattern reminiscent of synaptic structures (Kang and Kramer, 2000; Ackley et al., 2001).
To determine the localization of NID-1 and CLE-1 relative to synapses, we performed double-labeling experiments with antibodies against CLE-1 or NID-1 and a vesicular acetylcholine transporter, UNC-17, which is present in cholinergic presynaptic zones (Alfonso et al., 1993). At the light microscope level, it is not possible to determine whether NID-1 or CLE-1 is present within or excluded from synaptic clefts. However, these molecules are present at higher concentrations along the lateral region of the nerve cord, where synaptic junctions are abundant, relative to the medial region, which has many fewer synapses. The CLE-1 and NID-1 proteins appear to be present on different faces of the nerve cords relative to synaptic domains (Fig. 1). NID-1 is present lateral to the region where synapses form, between the nerve cord and the muscle. CLE-1 is concentrated between the nerve cords and the pseudocoelomic space or overlying muscle arms, i.e., along the dorsal face of the ventral nerve cord and the ventral face of the dorsal nerve cord (Fig. 1).
Although CLE-1 and NID-1 are found overlapping or closely apposed to UNC-17 along the nerve cords, we do not observe a consistent association of NID-1 or CLE-1 with UNC-17 puncta, and vice versa. UNC-17 is not present at all of the presynaptic zones in the nerve cords. We observe similar distributions of CLE-1 and NID-1 relative to a marker for GABAergic presynaptic zones, juIs1 (see below). NID-1 and CLE-1 are also detected in nonsynaptic regions of the nerve cords, but generally at significantly lower levels. We conclude that NID-1 and CLE-1 are enriched in regions where synapses form but are not synapse specific.
Mutations in cle-1 and nid-1 cause defects in synaptotagmin localization
Synaptotagmin is an endogenous component of synaptic vesicles found in all presynaptic zones (Nonet et al., 1993). To examine the significance of the CLE-1 and NID-1 associations with nerve cords, we examined the localization of synaptotagmin (SNT-1) incle-1 and nid-1 mutant animals. We examined thecle-1(cg120) allele, which is a deletion of the NC1 domain (Ackley et al., 2001), and two alleles of nid-1,cg118, an in-frame deletion of the G2 domain, andcg119, a deletion that removes the promoter and first six exons and is a molecular null (Kang and Kramer, 2000) (Fig.2). In wild-type dorsal and ventral nerve cords, SNT-1 is observed as discrete lines along the muscle edges. These lines represent numerous puncta that appear to run together. Along the sublateral nerve cords SNT-1 appears as individual puncta (Fig. 3).
In the nerve cords of cle-1(cg120) mutant animals, the SNT-1 staining pattern was observed as clusters of larger puncta that are not as tightly associated with the muscle edges. Along the sublateral nerve cords the size of the puncta appeared enlarged incle-1(cg120) relative to wild-type animals. Innid-1(cg119) null animals, SNT-1 appears diffused along the longitudinal axis of the nerve cord, and individual puncta are not generally distinguishable in the dorsal or ventral nerve cords.nid-1(cg118) animals displayed enlarged synapses along the ventral and dorsal nerve cords that were also often diffused along the axis of the cords. Antibody staining for UNC-10, a presynaptic active zone component (Koushika et al., 2001), showed defects similar to those observed for the entire presynaptic zones (data not shown).
A new cle-1 allele identified in a synapse-defective screen
Genetic screens have isolated mutations that cause morphological defects in presynaptic zone formation by visualizing the synaptic vesicle protein synaptobrevin (SNB) fused to GFP (Nonet, 1999; Zhen and Jin, 1999; Schaefer et al., 2000; Zhen et al., 2000; Crump et al., 2001). The presynaptic zone of the 19 GABAergic ventral cord motor neurons can be visualized using the unc-25 promoter to drive expression of SNB:: GFP (Jin et al., 1999; Nonet, 1999). This marker is observed as regularly sized and spaced individual puncta along the dorsal and ventral nerve cords (Fig.4). These puncta represent the presynaptic zones where the DD and VD motor neurons innervate the dorsal and ventral muscles, respectively.
Using this marker, we identified a mutation, ju34, which results in larger fluorescent puncta in the GABAergic motor neurons. We mapped ju34 to the region of LG1 near cle-1 and found that it failed to complement the cle-1(cg120) allele. Additionally, a transgene carrying the cosmid F39H11, which contains the complete wild-type cle-1 gene (Ackley et al., 2001), fully rescued the ju34 mutant phenotype. The ju34mutation results in loss of 29 of the 40 Gly-X-Y repeats in CLE-1 and places the downstream exons, which encode the NC1/endostatin domain, out of frame (for details, see Materials and Methods) (Fig. 2). Staining with an antibody directed against a CLE-1 epitope located C-terminal to the deletion, CeCol18 (Ackley et al., 2001), shows greatly reduced but detectable reactivity (data not shown). Similar results were obtained for the cle-1(cg120) deletion, which removes 45% of the epitope (Ackley et al., 2001). The small amount of CLE-1-specific immunoreactivity indicates that some protein can be produced and secreted, possibly via alternative splicing or read-through of the message, resulting in a reduced level of detectable protein. The two cle-1 alleles, cg120 andju34, are strong loss of function, but do not appear to be null mutations.
GABAergic NMJ defects in cle-1 mutants
We further examined synaptic defects in cle-1 mutants using the Punc-25:: SNB:: GFP (juIs1) marker to visualize individual presynaptic zones of GABAergic motor neuron synapses. Both ju34 andcg120 mutants showed similar abnormal SNB:: GFP puncta that appeared enlarged and more widely spaced than normal, and a decrease in the number of puncta in both the dorsal and ventral cords (Fig. 4, Table 1). Wild-type animals display ∼150 puncta in both the dorsal and ventral cords.cle-1(cg120) mutants display an average of 103 puncta in the ventral cord and 96 puncta in the dorsal cord, and ju34animals display an average of 102 ventral and 97 dorsal puncta. We calculated the area of the presynaptic zones in wild-type and mutant animals using the NIH Image program (see Materials and Methods). In wild-type animals the areas of presynaptic zones are 0.83 ± 0.96 μm2 along the ventral cord and 0.85 ± 0.36 μm2 along the dorsal cord. By contrast, in cle-1(cg120) mutants the ventral cord puncta are 2.77 ± 2.02 μm2, and the dorsal cord puncta are 2.02 ± 1.21 μm2. In ju34 animals the puncta are even larger, with the ventral cord puncta 4.25 ± 3.74 μm2 and the dorsal cord puncta 3.31 ± 1.21 μm2. The puncta appear both longer and wider in cg120 and ju34 animals (Fig.5, Table 1). The ju34 andcg120 alleles act like recessive, loss-of-function mutations, and heterozygous animals appear normal. The synaptic defects appear similar in each strain, although ju34 causes slightly larger puncta, suggesting that the defects may occur because of the loss of the NC1 domain, which is common to both mutations.
Because we observed both a reduction in number and an increase in size of the remaining SNB:: GFP puncta, we asked whether this effect could result from simple fusion of existing puncta or represents an independent effect on synaptic organization. We examined the total measurable synaptic area over a region of the nerve cord, a value that should not be altered if fusion is the only alteration in the mutants. Over a 100 μm distance, wild-type animals were observed to have 17.6 μm2 of SNB:: GFP fluorescence.cle-1(cg120) animals were observed to have 23.1 μm2 and cle-1(ju34) animals to have 46.3 μm2 of fluorescence. These results suggest that the increase in synaptic area does not simply result from fusion of neighboring synapses, but rather involves a defect in synaptic morphology.
GABAergic NMJ defects in nid-1 mutants
Because NID-1 is also concentrated along the synaptic zone of the nerve cords and nid-1 mutations cause defects in synaptotagmin accumulation, we examined the two nid-1mutations using SNB:: GFP and found both to be defective. Incg119 animals the puncta on the dorsal and ventral nerve cords are affected differently. Along the ventral nerve cord the puncta appear smaller and often smeared, with an apparent increase in the number of puncta. The average area of ventral puncta is 5.56 ± 9.24 μm2. The dorsal puncta appear more normal but are slightly enlarged, with an average area of 1.15 ± 0.65 μm2 (Figs. 4, 5, Table 1). The puncta in cg119 animals are a mix of small puncta and elongated puncta that appear three to four times longer than in wild-type. These puncta are likely to result from several smaller puncta that have run together, thus dramatically increasing the variability in size of puncta. The dorsal nerve cord exhibits similar small, smeary puncta interspersed with larger, clumped puncta, with no change in the number of puncta (Fig. 4, Table 1).
The NID-1 G2 domain deletion, cg118, has a different effect, with the puncta appearing more spread out and disorganized, occasionally enlarged, and often a decreased number of apparent puncta (Fig. 4, Table 1). Similar defects are observed on both the dorsal and ventral nerve cords. The average area of ventral puncta is 2.01 ± 3.74 μm2, and the area of dorsal puncta is 1.38 ± 1.14 μm2 (Fig. 5, Table1).
Presynaptic defects are not necessarily secondary to axon positioning defects
Because axon guidance defects have been demonstrated incle-1 and nid-1 mutants, we were curious about whether the synaptic defects were a secondary effect of positioning defects. We examined the penetrance of axon positioning defects along the ventral nerve cord in these animals using a GFP marker that reveals the cell bodies and processes of 6 DD and 13 VD motor neurons,juIs76[Punc-25:: GFP] (see Materials and Methods).
We observed ventral cord defasciculation defects in 23% ofcle-1 animals. On average, in each animal that exhibited any defect only 2.7% of all axons were detectably defective. Fifty-two percent of nid-1(cg118) and 50% of nid-1(cg119) animals exhibited positioning defects, with an average of 6.6 and 5.4%, respectively, of the axons examined exhibiting a defect. In contrast, synaptic defects were observed in 100% of the mutant animals and were seen throughout the nerve cords, not confined to single axons. These results suggest that defects in synaptic organization are present on axons that are not obviously mispositioned. Furthermore, the nature of the synaptic defects is distinct in cle-1 andnid-1 mutants, indicating that they have some specific effect on synapse organization. These results make it very unlikely that the highly penetrant synaptic defects are simply the result of axon guidance defects.
Similar presynaptic and postsynaptic defects incle-1 and nid-1 mutants
An essential feature of synapses is the precise registry of the presynaptic and postsynaptic structures. Recent studies have demonstrated a role for the ECM in the coordinate formation of presynaptic and postsynaptic structures (Nguyen et al., 2000). We asked whether the presynaptic defects in cle-1 andnid-1 mutants were correlated with defects in the postsynaptic structures in muscle cells. We visualized GABAergic postsynaptic NMJ structures using a functional GFP-tagged GABA receptor, UNC-49B (Bamber et al., 1999). We observed defects in the pattern of the UNC-49B:: GFP marker that correlated with those seen with the SNB:: GFP marker in cle-1 andnid-1 mutants (Fig. 6). In both cle-1 mutants the puncta appear enlarged, rounded, and spaced farther apart than normal. nid-1(cg119) animals exhibited elongated puncta interspersed with smaller smeary puncta. nid-1(cg118) animals have a mix of small puncta and elongated puncta that are spread farther apart. These results demonstrate that both presynaptic and postsynaptic structures are affected in cle-1 and nid-1 mutants and reinforce the concept that synaptogenesis is a coordinated process between neurons and their target cells.
Synaptic defects in cle-1 appear to function cell nonautonomously
Because CLE-1 and NID-1 are secreted and incorporated into the extracellular matrix, we asked whether their expression was specifically required in neurons or muscles. We conducted mosaic analysis in cle-1(cg120) animals that carried acle-1(+) cosmid and SUR-5:: GFP as a marker for cells that either retained (GFP+) or lost (GFP−) the extrachromosomal array (see Materials and Methods). Four animals that had lost the array from the muscle lineage were scored for SNB:: GFP puncta shape and distribution and were found to be wild type. Two animals that had lost the array along large portions of the ventral nerve cord were also found to have wild-type puncta. Thus, the synaptic defects incle-1(cg120) animals were rescued equally well when the array was lost from the muscle lineage or neural lineage, indicating that CLE-1 functions cell nonautonomously. Previous data have indicated that NID-1 also acts cell nonautonomously with regard to axon guidance (Kim and Wadsworth, 2000), because either muscle or neural-specific expression was capable of rescuing axonal defects. These results are consistent with previous reports for extracellular matrix molecules acting cell nonautonomously in C. elegans (Graham et al., 1997).
cle-1 and nid-1 exhibit movement defects in a thrashing assay
The movement of cle-1 and nid-1 mutant animals on normal growth media plates appears essentially wild type, despite the highly penetrant synaptic structure defects described here and the axonal defects described previously (Kim and Wadsworth, 2000;Ackley et al., 2001). To assess whether these mutations could result in more subtle effects on movement, animals were examined using a thrashing assay (Miller et al., 1996). Thrashing is a high-frequency locomotory behavior that occurs when animals are placed in liquid. In this behavior there is a coordinated movement in which the animal brings the head and tail toward each other, flexing around the approximate midpoint with a regular amplitude and alternation between ventral and dorsal flexure (supplemental materials). Animals with defects in synaptic transmission exhibit reductions in the rate of thrashing behavior (Miller et al., 1996).
Wild-type animals thrash at an average rate of 162.5 thrashes per minute (TPM). A decrease in the rate of thrashing was observed forcle-1(cg120) (123 TPM) and nid-1(cg119) (130 TPM). Additionally, the mutant animals exhibited uncoordinated movements of the head and tail that were not observed in wild-type animals. For example, in cle-1(cg120) mutants the head and tail often move in opposite directions or one is static while the other is moving, behaviors that are very rarely observed in wild-type animals (Fig. 7) (supplemental movies; available at www.jneurosci.org). The mutants also frequently over-bend, such that the head and tail cross over one another. Interestingly,nid-1(cg118) ΔG2 animals displayed an increase in thrashes per minutes (172 TPM) relative to wild-type, but with a decrease in the amplitude of the behavior (Fig. 7) (supplemental movies, available atwww.jneurosci.org). cg118 animals also show uncoordinated movements of the head and tail, although at lower penetrance. Our results suggest that the axonal positioning and/or synaptic structure defects in cle-1 and nid-1 mutants can result in loss of normal coordination of body wall muscle contraction.
Because CLE-1 and NID-1 also accumulate under body wall muscles (Kang and Kramer, 2000; Ackley et al., 2001), it is possible that defects in muscle cell function contribute to the observed movement defects. However, staining for UNC-52 perlecan (Fig. 3) demonstrates that dense bodies are formed normally in the mutant animals. Furthermore, staining with myosin-specific antisera demonstrated no observable defects in the organization of thick filaments in mutant animals (data not shown). Given that we observe multiple defects in the organization of the nervous system, the most penetrant of which are synaptic, it is likely that the synaptic defects are a major cause of the movement defects detected in the thrashing assays.
Response to a cholinergic agonist is altered innid-1 and cle-1 mutants
To assess whether synaptic transmission is altered incle-1 and nid-1 mutants, we measured egg laying in response to the acetylcholine agonist levamisole (Lewis et al., 1980b, 1987; Waggoner et al., 2000). In the presence of levamisole, wild-type animals are stimulated to lay eggs in a dose-dependent manner. Both nid-1 mutants showed a strongly decreased egg-laying response, indicating reduced cholinergic transmission in the egg-laying muscles of these animals (Fig.8A, Table 2).cle-1 animals have a highly variable response to levamisole. The mean number of eggs laid does not differ from wild type, but the range of responses is much greater than wild type (Table 2). At all but the lowest levamisole concentration, there are cle-1 mutants that lay more and fewer eggs than wild-type animals. cle-1mutants are often egg-laying defective (Egl), retaining larger than normal numbers of eggs in the uterus (Ackley et al., 2001), and stimulation of Egl animals could result in release of a larger number of eggs than normal. Notably, some cle-1 mutants fail to lay any eggs even at high levamisole concentrations, indicating that some animals are resistant. The increased range of egg laying, even at lower doses, indicates that cle-1 animals respond differently to levamisole than wild-type animals, suggesting that cholinergic transmission is altered. We observe different responses to levamisole in cle-1 and nid-1 animals, indicating that the loss of each molecule causes distinct defects in cholinergic transmission.
nid-1 and cle-1 mutants are resistant to aldicarb
To further assess synaptic functional defects, we analyzed the response of mutant animals to the cholinesterase inhibitor aldicarb. When cultured on aldicarb-containing media for 8 hr, wild-type animals display a dose-dependent loss of movement, cessation of pharyngeal pumping, and lethality caused by accumulation of toxic levels of acetylcholine in synaptic clefts. Mutations that reduce cholinergic transmission show resistance to aldicarb (Miller et al., 1996).nid-1(cg119) null mutants were highly resistant to aldicarb, with only 50% of null animals exhibiting lethality at the highest dose tested (Fig. 8, Table 3). Bothcle-1 mutants and the nid-1(cg118) animals were also resistant to aldicarb-induced lethality, but to a lesser degree than the nid-1 null mutant. The accumulation of acetylcholine causes paralysis of body wall muscles. All wild-type animals become completely paralyzed at 0.9 mmaldicarb, whereas nid-1(cg118) and cle-1 animals require 1.7 mm aldicarb for complete paralysis. Even at 1.9 mm aldicarb, 31% ofnid-1(cg119) continue to exhibit body wall muscle contractions. These data further support the conclusion that synaptic transmission is impaired in these mutant animals.
Discussion
The nerve ring and nerve cords of C. elegans are closely associated with basement membranes (White et al., 1986). Five major BM molecules have been characterized in C. elegans. Three of these, type IV collagen, perlecan and SPARC, are not found in association with the nerve ring or cords and are not concentrated at muscle edges adjacent to the cords (Graham et al., 1997; Fitzgerald and Schwarzbauer, 1998; Mullen et al., 1999). However, both NID-1 and CLE-1 are found in association with the nervous system in these locations (Kang and Kramer, 2000; Ackley et al., 2001), indicating a potential role for them in nervous system function. Neither NID-1 nor CLE-1 is restricted to the nervous system, because both are detectable at varying levels in most or all basement membranes throughout the animal. Along the nerve cords, CLE-1 and NID-1 show differences in their localizations. Relative to the position of UNC-17, a component of cholinergic presynaptic zones, CLE-1 appears most highly concentrated along the pseudocoelomic face of the nerve cords, i.e., on the dorsal face of the ventral cord and the ventral face of the dorsal cord. In contrast, NID-1 appears most highly concentrated laterally, lying between the tightly apposed nerve cords and body wall muscles.
Although CLE-1 and NID-1 can be found in close association with synaptic markers, their distribution patterns do not directly coincide with synapses. Despite this fact, we have presented evidence that they can affect synapse organization and function. Molecules that can affect synapses need not be synapse specific or localized directly at active zones. For example, the recently described periactive zone (Sone et al., 2000) is separate from the synaptic active zone and does not contain synaptic vesicles. Some widely expressed molecules, e.g., βPS integrin and disks large, have been shown to accumulate in the periactive zone and to be required for proper synaptic morphology and function in Drosophila (Beumer et al., 1999; Sone et al., 2000). The presence of CLE-1 and NID-1 in close proximity to synapse-rich regions of the nervous system is consistent with their having a role in synaptic organization.
Functional significance of CLE-1 and NID-1 association with the nerve cords was supported by the observation that mutations incle-1 and nid-1 result in distinct defects in synaptic structures. These genes have multiple roles in neurogenesis, including cell migrations and axon guidance (Kim and Wadsworth, 2000;Ackley et al., 2001) and, as shown here, synapse organization. The synaptic organization defects of cle-1 and nid-1mutants could arise as a secondary consequence of axon guidance defects. However, the cell migration and axon guidance defects ofcle-1 and nid-1 mutants have relatively low penetrance, whereas the synaptic defects reported here are fully penetrant. Also, mutants in the two genes display structurally distinct synaptic defects, indicating that axon mispositioning alone cannot account for the synaptic abnormalities. Together these results indicate that interactions with CLE-1 and NID-1 are required at multiple stages of neurogenesis, from the initial events of cell migration through the wiring stage of synaptogenesis. Expression of nid-1 andcle-1 is detectable before the onset of the morphogenetic phase of embryogenesis, before the formation of the nervous system (Kang and Kramer, 2000; Ackley et al., 2001).
We observe defects in both presynaptic and postsynaptic structures. Previous work has shown that molecules that function specifically in the presynaptic neurons can affect the organization of the postsynaptic structure (Zhen and Jin, 1999), although mechanistically it was unclear how this occurred. Our data suggest that the coordinate formation could be mediated, at least in part, by components of the ECM. In mice, α4 chain-containing laminins are concentrated between the presynaptic active zone and the postsynaptic receptor clefts, which are not properly aligned in mice lacking the laminin α4 chain (Patton et al., 2001).
The uncoordinated movement seen in thrashing assays and the altered responses to levamisole, a cholinergic agonist, and aldicarb, a cholinesterase inhibitor, suggest that synaptic transmission is impaired in cle-1 and nid-1 mutant animals. Because these mutants have axon-positioning and synapse-organization abnormalities, the defects observed in these assays could result from either or both of these abnormalities. Genetic screens in C. elegans for resistance to cholinesterase inhibitors have been very successful at identifying molecules that regulate synaptic transmission but have not reportedly identified molecules that affect axon guidance (Jorgensen et al., 1995; Miller et al., 1996). Neither cle-1nor nid-1 mutants are as strongly resistant as the strongest mutations identified in these screens. However, their altered responses to cholinergic modulators most likely reflect defects in synaptic transmission.
The distinct structural defects in synaptic structures seen incle-1 and nid-1 mutants suggest that these molecules have specific roles in synapse organization. Incle-1 mutants, synaptic structures in the dorsal and ventral cords are enlarged and spaced farther apart than in wild-type animals, with an apparent reduction in number of synapses. Both cle-1mutations, cg120 and ju34, result in loss of the type XVIII collagen NC1 domain, suggesting that the loss of this domain may cause the defects observed. The NC1/endostatin domain has been shown to bind integrins (Rehn et al., 2001) and could interact directly with cells during organization of synapses. The NC1 domain has been shown to stimulate cell motility (Kuo et al., 2001) and bind the laminin–nidogen complex, as well as other ECM molecules (Sasaki et al., 1998). Thus, the defects of synaptic organization seen incle-1 mutants could be caused by problems in the migrations of presynaptic or postsynaptic cells or in the presentation of the ECM to these cells during synaptogenesis.
The nid-1 null mutant shows slightly different defects in the dorsal and ventral cords. In both, synapses are elongated along the length of the cord and more closely spaced than normal. Along the ventral cord the puncta appear narrowed and fragmented, whereas on the dorsal cord an increase in size is observed. The reason for this difference is unknown. One possibility is that the VD motor neurons, which form the ventral synapses, and the DD motor neurons, which form the dorsal synapses, respond differently to the absence of nidogen. Thecg118 NID-1(ΔG2) mutants show more similar defects in the dorsal and ventral cords, with less severely enlarged and aberrantly spaced puncta than seen in the null mutants.
Nidogen has been suggested to link together laminin and collagen IV or perlecan polymer networks in basement membranes on the basis of the binding of its G2 domain to type IV collagen and perlecan and of its G3 domain to laminin (Aumailley et al., 1993; Reinhardt et al., 1993). We generally observed less severe defects in NID-1(ΔG2) animals relative to the null animals, particularly in resistance to levamisole and aldicarb. NID-1(ΔG2) was also previously shown to result in less severe loss of fecundity than the NID-1 null (Kang and Kramer, 2000). Together these results indicate that loss of the G2 domain causes only a partial reduction in nidogen function and argues that the proposed linking role for nidogen cannot account for all of its functions. The finding of neurological defects in nidogen-1/entactin-1-deficient mice (Dong et al., 2002) suggests that the axonal and synaptic defects described for C. elegans nid-1 mutants may also occur in these mice.
Synapse formation is a highly complex process that requires multiple dynamic interactions between neurons and target cells. We have shown that CLE-1 and NID-1 are associated with the nervous system in C. elegans and are required for proper synapse organization and function. Understanding how these molecules function to specify synaptic formation is an ongoing challenge. This is the first demonstration of a role for these proteins during synaptogenesis, but reinforces the utility of C. elegans for identifying novel players in the process of synaptogenesis.
Footnotes
This work was supported by grants from the National Institutes of Health (NIH) (J.M.K., Y.J.). Y.J. is an Assistant Investigator of the Howard Hughes Medical Institute. We thank M. Nonet and A. Alfonso for providing antibodies. Some strains used in these studies were provided by the Caenorhabditis elegans Genetics Center, which is supported by the NIH Center for Research Resources.
Correspondence should be addressed to James M. Kramer, Department of Cell and Molecular Biology, Northwestern University Medical School, 303 East Chicago Avenue, Chicago, IL 60611. E-mail:jkramer{at}northwestern.edu.